Benefits and harms of 'smart drugs'(nootropics) in healthy individuals
F Schifano, V Catalani, S Sharif, F Napoletano… - Drugs, 2022 - Springer
Abstract 'Smart drugs'(also known as 'nootropics' and 'cognitive enhancers'[CEs]) are being
used by healthy subjects (ie students and workers) typically to improve memory, attention …
used by healthy subjects (ie students and workers) typically to improve memory, attention …
Methylphenidate for attention-deficit/hyperactivity disorder in adults: a narrative review
RR Jaeschke, E Sujkowska, M Sowa-Kućma - Psychopharmacology, 2021 - Springer
Rationale Psychostimulants, including methylphenidate (MPH), are the mainstay of
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …
pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) in adults. Even though …
Gaze-based attention refocusing training in virtual reality for adult attention-deficit/hyperactivity disorder
Background Attention-deficit/hyperactivity disorder (ADHD) is characterized by substantial
interindividual heterogeneity that challenges the systematic assessment and treatment …
interindividual heterogeneity that challenges the systematic assessment and treatment …
Long-term methylphenidate use for children and adolescents with attention deficit hyperactivity disorder and risk for depression, conduct disorder, and psychotic …
Background Methylphenidate (MPH) is the most frequently prescribed medication for the
treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long …
treatment of attention deficit hyperactivity disorder (ADHD). However, the safety of its long …
P300 Modulation via Transcranial Alternating Current Stimulation in Adult Attention-Deficit/Hyperactivity Disorder: A Crossover Study
Objective A repeated finding regarding event-related potentials (ERPs) is that patients with
ADHD show a reduced P300 amplitude. This raises the question of whether the attention of …
ADHD show a reduced P300 amplitude. This raises the question of whether the attention of …
Neuroplasticity to autophagy cross-talk in a therapeutic effect of physical exercises and irisin in ADHD
A Abdulghani, M Poghosyan, A Mehren… - Frontiers in molecular …, 2023 - frontiersin.org
Adaptive neuroplasticity is a pivotal mechanism for healthy brain development and
maintenance, as well as its restoration in disease-and age-associated decline. Management …
maintenance, as well as its restoration in disease-and age-associated decline. Management …
Alpha modulation via transcranial alternating current stimulation in adults with attention-deficit hyperactivity disorder
Background One potential therapy treating attention-deficit/hyperactivity disorder (ADHD) is
to modulate dysfunctional brain activations using brain stimulation techniques. While the …
to modulate dysfunctional brain activations using brain stimulation techniques. While the …
Symptoms associated with ADHD/treatment-related adverse side effects and their impact on quality of life and work productivity in adults with ADHD
J Schein, M Cloutier, M Gauthier-Loiselle… - Current Medical …, 2023 - Taylor & Francis
Objective Describe symptoms associated with ADHD/treatment-related adverse side effects
among adults with ADHD in the US and assess their impact on quality of life (QoL) and work …
among adults with ADHD in the US and assess their impact on quality of life (QoL) and work …
Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
K Boesen, AS Paludan-Müller… - Cochrane Database …, 2022 - cochranelibrary.com
Background Attention deficit hyperactivity disorder (ADHD) is a psychiatric diagnosis
increasingly used in adults. The recommended first‐line pharmacological treatment is …
increasingly used in adults. The recommended first‐line pharmacological treatment is …
[HTML][HTML] Adverse events during dosing of delayed-release/extended-release methylphenidate: learnings from the open-label phase of a registration trial and a real …
MA Katzman, V Otcheretko, MD Po, CL Uchida… - Clinical Therapeutics, 2023 - Elsevier
Purpose Delayed-release/extended-release methylphenidate (DR/ER-MPH)(formerly
HLD200) is an evening-dosed agent used for the treatment of attention-deficit/hyperactivity …
HLD200) is an evening-dosed agent used for the treatment of attention-deficit/hyperactivity …